HIIT in Youth With Congenital Heart Disease (MedBIKE)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorUniversity of Alberta

About this trial

Congenital heart disease (CHD), the most common birth defect, is present in nearly 1% of the population. CHD patients are associated with intense resource utilization and premature death in adulthood. The risk of premature death is linked with reduced exercise capacity, a finding consistently noted in youth with CHD. Reduced exercise capacity in this population has also been associated with reduce physical activity and health-related quality of life.

Cardiac rehabilitation (CR) in adults with acquired heart disease is an established secondary prevention strategy that improves exercise capacity. The investigators propose a prospective clinical trial of a home-based high intensity interval training (HIIT) program using a novel telemedicine-equipped video game-linked cycle ergometer (MedBIKE™) for 10 to 18 year olds with repaired moderate-complex CHD. The pilot study with the MedBIKE has shown promising results. The investigators now seek to study the efficacy of this program in a broader CHD population.

Eligibility criteria

Qualifiers

Children and adolescents aged 10-18 years

Repaired moderate-complex congenital heart disease

Disqualifiers

Non-English speaking (thus limiting communication during the MedBIKE™ sessions)

Home environment cannot accommodate the MedBIKE™ system (space limitations)

Previous involvement in a cardiac rehab or exercise intervention program

Primary cardiologist has exercise restricted the participant or counsels against participation

Trial design

Treatments tested in this trial

  • MedBIKE HIIT

Treatment groups

44 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Alberta

Lead sponsor

Heart and Stroke Foundation of Canada

Collaborator